Juan Pablo Muñoz Pérez (Juan Pablo Muñoz)

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 4

Top Topics

Stem Cell Transplantation

Radiation Induced

Hodgkin Lymphoma

Top Venues

Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery

This page only lists publications with an associated author ORCID identifier.

Publications

Jaume Mora, Alicia Castañeda, Maite Gorostegui, Amalia Varo, Sara Perez-Jaume, Margarida Simao, Juan Pablo Muñoz Pérez, Moira Garraus, Cristina Larrosa, Noelia Salvador, Cinzia Lavarino, Lucas Krauel, Salvador Mañe
Naxitamab Combined with Granulocyte-Macrophage Colony-Stimulating Factor as Consolidation for High-Risk Neuroblastoma Patients in First Complete Remission under Compassionate Use-Updated Outcome Report. Cancers 15 (9) (2023)
Jaume Mora, Alicia Castañeda, Maite Gorostegui, Amalia Varo, Sara Perez-Jaume, Margarida Simao, Juan Pablo Muñoz Pérez, Moira Garraus, Cristina Larrosa, Noelia Salvador, Cinzia Lavarino, Lucas Krauel, Salvador Mañe
Naxitamab Combined with Granulocyte-Macrophage Colony-Stimulating Factor as Consolidation for High-Risk Neuroblastoma Patients in First Complete Remission under Compassionate Use-Updated Outcome Report. Cancers 15 (9) (2023)
Juan Pablo Muñoz Pérez, Jordi Muchart, Vicente Santa-María López, Mariona Suñol Capella, Noelia Salvador, Sara Pérez Jaume, Ofelia Cruz Martínez, Andrés Morales La Madrid
Targeted therapy for pediatric low-grade glioma. Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery 37 (8) (2021)
Jaume Mora, Alicia Castañeda, Maria Cecilia Colombo, Maite Gorostegui, Fernando Gómez Muñoz, Salvador Mañe, Vicente Santa-Maria, Moira Garraus, Napoleon Macias, Sara Perez-Jaume, Oscar Muñoz, Juan Pablo Muñoz Pérez, Ignasi Barber, Mariona Suñol
Clinical and Pathological Evidence of Anti-GD2 Immunotherapy Induced Differentiation in Relapsed/Refractory High-Risk Neuroblastoma. Cancers 13 (6) (2021)